The Experts below are selected from a list of 1881 Experts worldwide ranked by ideXlab platform

Yongliang Sun - One of the best experts on this subject based on the ideXlab platform.

  • Laparoscopic surgery for giant Liver Hemangiomas: a report of 40 patients
    Chinese Journal of Hepatobiliary Surgery, 2018
    Co-Authors: Zhiying Yang, Xiaolei Liu, Haidong Tan, Yongliang Sun, Liguo Liu, Wenying Zhou
    Abstract:

    Objective To analyze the clinical experience of laparoscopic surgery for giant Liver Hemangiomas. Methods The clinical data of 40 patients who underwent laparoscopic surgery for giant Liver Hemangiomas from August 2012 to January 2018 in the China-Japan Friendship Hospital were retrospectively analyzed. The diameters of the Liver Hemangiomas were more than 10 cm for all the patients. The Liver functions of all the patients were Child-Pugh class A. The follow-up was up to the end of February 2018. Results Laparoscopic treatment of giant Liver Hemangioma was successfully performed in 37 patients. Three patients were converted to open hepatectomy. The mean diameter of the giant Liver Hemangiomas was (10.8±1.3) cm (ranged 10.0~15.0 cm). The mean operative time for laparoscopic therapy was (154.7±68.0) min (range 70~390 min). The mean intraoperative blood loss was 200 (100~400) ml. 20 patients received autologous blood transfusion. Of these 2 patients received in addition allogeneic blood transfusion. The postoperative hospital stay was (6.9±2.0) days (range 4~14 days). Postoperative complications occurred in 3 patients (8.1%). Two patients developed postoperative pleural effusion and one pelvic effusion. Two patients responded well to puncture drainage and one to conservation management. There was no postoperative hemorrhage, bile leakage or air embolism. All patients were followed-up and no Liver Hemangioma recurrence was detected. Conclusion Laparoscopic surgery was a safe and efficacious procedure in selected patients with giant Liver Hemangioma. Key words: Liver Hemangioma; Laparoscopic surgery; Hepatectomy

  • Surgical treatment for giant Liver Hemangioma: an expeience on 119 cases
    Chinese Journal of General Surgery, 2018
    Co-Authors: Haidong Tan, Xiaolei Liu, Yongliang Sun, Liguo Liu, Jia Huang, Wenying Zhou
    Abstract:

    Objective To summarize the experience of surgical treatments for giant Liver Hemangioma. Methods A retrospective study was made on the clinical data of patients with Liver Hemangioma larger than 10 cm in diameter, which were divided into two groups (10-

  • long term result of transcatheter arterial embolization for Liver Hemangioma
    Medicine, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Liguo Liu, Jia Huang, Yongliang Sun
    Abstract:

    Transcatheter arterial embolization (TAE) is a method for the treatment of Liver Hemangioma, but fewer studies reported the long-term result.Retrospective study was conducted to Liver Hemangioma patients who received TAE. The inclusion criteria included the following: the period of follow-up was more than 5 years; and patients were followed up for less than 5 years, but received surgical treatment due to the enlargement of tumor or severe complications of TAE. The collected data included sex, age, size of the tumor, times of TAE, complications, period of follow-up, long-term result, and whether or not surgery was finally performed.Fifty-five patients were included, and the average age was 43.1 ± 8.6 years. The average size of Liver Hemangioma was 9.0 ± 4.3 cm. Four patients (7.3%) had severe complications after TAE, including 2 cases of biloma which were cured by surgery. The tumor size was smaller or the same in 19 patients after 5 years follow-up, and the long-term effective rate was 35.8%. The size of tumor became larger in the other 34 patients (64.2%), and 29 patients (54.7%) received surgery finally. The long-term effective rate for patients with ≥10 cm tumor and <10 cm tumor were 12.5% and 45.9%, respectively, and the difference was significant (P = .019).The long-term result of TAE for Liver Hemangioma was not satisfying, and the treatment had the risk of severe complication. For patients with asymptomatic Liver Hemangioma, TAE should not be conducted.

  • Risk factors of massive blood loss during resection of giant Liver Hemangioma
    Chinese Journal of Hepatobiliary Surgery, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Yongliang Sun, Liguo Liu, Wenying Zhou
    Abstract:

    Objective To evaluate the risk factors of massive blood loss in resection of giant Liver Hemangioma. Method The clinical data of 141 patients who underwent giant Liver Hemangioma resection were retrospectively studied. These data included general physical condition, laboratory tests, radiologic findings, and various surgical parameters. The patients were divided into the massive blood loss group (>1 000 ml, n=27) and the minor blood loss group (≤1 000 ml, n=114). Logistic regression was performed to determine the risk factors of intraoperative massive blood loss. Results The average diameter of the Liver Hemangioma was significantly greater in the massive blood loss group than that in the minor blood loss group [(21.7±8.5) cm vs. (14.1±5.3) cm, P

  • Extremely Giant Liver Hemangioma (50 cm) with Kasabach-Merritt Syndrome.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2017
    Co-Authors: Zhiying Yang, Xiaolei Liu, Haidong Tan, Yongliang Sun
    Abstract:

    A 33-year-old male has been found with a giant Liver Hemangioma of initial size 29 cm for 5 years. He received arterial embolization twice in order to shrink the tumor; however, no effect was obtained. The tumor had rapidly grown to 50 cm and caused abnormalities in the hematological and coagulative systems. Preoperative computed tomography revealed that the right hepatic vein, right hepatic artery, and right portal vein were not involved by the Hemangioma. Resection of the giant Liver Hemangioma was successfully performed after intraoperative intentional bloodletting with concurrent blood salvage. All hematological and coagulative abnormalities had returned to normal after the procedure.

Xiaolei Liu - One of the best experts on this subject based on the ideXlab platform.

  • Laparoscopic surgery for giant Liver Hemangiomas: a report of 40 patients
    Chinese Journal of Hepatobiliary Surgery, 2018
    Co-Authors: Zhiying Yang, Xiaolei Liu, Haidong Tan, Yongliang Sun, Liguo Liu, Wenying Zhou
    Abstract:

    Objective To analyze the clinical experience of laparoscopic surgery for giant Liver Hemangiomas. Methods The clinical data of 40 patients who underwent laparoscopic surgery for giant Liver Hemangiomas from August 2012 to January 2018 in the China-Japan Friendship Hospital were retrospectively analyzed. The diameters of the Liver Hemangiomas were more than 10 cm for all the patients. The Liver functions of all the patients were Child-Pugh class A. The follow-up was up to the end of February 2018. Results Laparoscopic treatment of giant Liver Hemangioma was successfully performed in 37 patients. Three patients were converted to open hepatectomy. The mean diameter of the giant Liver Hemangiomas was (10.8±1.3) cm (ranged 10.0~15.0 cm). The mean operative time for laparoscopic therapy was (154.7±68.0) min (range 70~390 min). The mean intraoperative blood loss was 200 (100~400) ml. 20 patients received autologous blood transfusion. Of these 2 patients received in addition allogeneic blood transfusion. The postoperative hospital stay was (6.9±2.0) days (range 4~14 days). Postoperative complications occurred in 3 patients (8.1%). Two patients developed postoperative pleural effusion and one pelvic effusion. Two patients responded well to puncture drainage and one to conservation management. There was no postoperative hemorrhage, bile leakage or air embolism. All patients were followed-up and no Liver Hemangioma recurrence was detected. Conclusion Laparoscopic surgery was a safe and efficacious procedure in selected patients with giant Liver Hemangioma. Key words: Liver Hemangioma; Laparoscopic surgery; Hepatectomy

  • Surgical treatment for giant Liver Hemangioma: an expeience on 119 cases
    Chinese Journal of General Surgery, 2018
    Co-Authors: Haidong Tan, Xiaolei Liu, Yongliang Sun, Liguo Liu, Jia Huang, Wenying Zhou
    Abstract:

    Objective To summarize the experience of surgical treatments for giant Liver Hemangioma. Methods A retrospective study was made on the clinical data of patients with Liver Hemangioma larger than 10 cm in diameter, which were divided into two groups (10-

  • long term result of transcatheter arterial embolization for Liver Hemangioma
    Medicine, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Liguo Liu, Jia Huang, Yongliang Sun
    Abstract:

    Transcatheter arterial embolization (TAE) is a method for the treatment of Liver Hemangioma, but fewer studies reported the long-term result.Retrospective study was conducted to Liver Hemangioma patients who received TAE. The inclusion criteria included the following: the period of follow-up was more than 5 years; and patients were followed up for less than 5 years, but received surgical treatment due to the enlargement of tumor or severe complications of TAE. The collected data included sex, age, size of the tumor, times of TAE, complications, period of follow-up, long-term result, and whether or not surgery was finally performed.Fifty-five patients were included, and the average age was 43.1 ± 8.6 years. The average size of Liver Hemangioma was 9.0 ± 4.3 cm. Four patients (7.3%) had severe complications after TAE, including 2 cases of biloma which were cured by surgery. The tumor size was smaller or the same in 19 patients after 5 years follow-up, and the long-term effective rate was 35.8%. The size of tumor became larger in the other 34 patients (64.2%), and 29 patients (54.7%) received surgery finally. The long-term effective rate for patients with ≥10 cm tumor and <10 cm tumor were 12.5% and 45.9%, respectively, and the difference was significant (P = .019).The long-term result of TAE for Liver Hemangioma was not satisfying, and the treatment had the risk of severe complication. For patients with asymptomatic Liver Hemangioma, TAE should not be conducted.

  • Risk factors of massive blood loss during resection of giant Liver Hemangioma
    Chinese Journal of Hepatobiliary Surgery, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Yongliang Sun, Liguo Liu, Wenying Zhou
    Abstract:

    Objective To evaluate the risk factors of massive blood loss in resection of giant Liver Hemangioma. Method The clinical data of 141 patients who underwent giant Liver Hemangioma resection were retrospectively studied. These data included general physical condition, laboratory tests, radiologic findings, and various surgical parameters. The patients were divided into the massive blood loss group (>1 000 ml, n=27) and the minor blood loss group (≤1 000 ml, n=114). Logistic regression was performed to determine the risk factors of intraoperative massive blood loss. Results The average diameter of the Liver Hemangioma was significantly greater in the massive blood loss group than that in the minor blood loss group [(21.7±8.5) cm vs. (14.1±5.3) cm, P

  • Extremely Giant Liver Hemangioma (50 cm) with Kasabach-Merritt Syndrome.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2017
    Co-Authors: Zhiying Yang, Xiaolei Liu, Haidong Tan, Yongliang Sun
    Abstract:

    A 33-year-old male has been found with a giant Liver Hemangioma of initial size 29 cm for 5 years. He received arterial embolization twice in order to shrink the tumor; however, no effect was obtained. The tumor had rapidly grown to 50 cm and caused abnormalities in the hematological and coagulative systems. Preoperative computed tomography revealed that the right hepatic vein, right hepatic artery, and right portal vein were not involved by the Hemangioma. Resection of the giant Liver Hemangioma was successfully performed after intraoperative intentional bloodletting with concurrent blood salvage. All hematological and coagulative abnormalities had returned to normal after the procedure.

Jia Huang - One of the best experts on this subject based on the ideXlab platform.

  • Surgical treatment for giant Liver Hemangioma: an expeience on 119 cases
    Chinese Journal of General Surgery, 2018
    Co-Authors: Haidong Tan, Xiaolei Liu, Yongliang Sun, Liguo Liu, Jia Huang, Wenying Zhou
    Abstract:

    Objective To summarize the experience of surgical treatments for giant Liver Hemangioma. Methods A retrospective study was made on the clinical data of patients with Liver Hemangioma larger than 10 cm in diameter, which were divided into two groups (10-

  • long term result of transcatheter arterial embolization for Liver Hemangioma
    Medicine, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Liguo Liu, Jia Huang, Yongliang Sun
    Abstract:

    Transcatheter arterial embolization (TAE) is a method for the treatment of Liver Hemangioma, but fewer studies reported the long-term result.Retrospective study was conducted to Liver Hemangioma patients who received TAE. The inclusion criteria included the following: the period of follow-up was more than 5 years; and patients were followed up for less than 5 years, but received surgical treatment due to the enlargement of tumor or severe complications of TAE. The collected data included sex, age, size of the tumor, times of TAE, complications, period of follow-up, long-term result, and whether or not surgery was finally performed.Fifty-five patients were included, and the average age was 43.1 ± 8.6 years. The average size of Liver Hemangioma was 9.0 ± 4.3 cm. Four patients (7.3%) had severe complications after TAE, including 2 cases of biloma which were cured by surgery. The tumor size was smaller or the same in 19 patients after 5 years follow-up, and the long-term effective rate was 35.8%. The size of tumor became larger in the other 34 patients (64.2%), and 29 patients (54.7%) received surgery finally. The long-term effective rate for patients with ≥10 cm tumor and <10 cm tumor were 12.5% and 45.9%, respectively, and the difference was significant (P = .019).The long-term result of TAE for Liver Hemangioma was not satisfying, and the treatment had the risk of severe complication. For patients with asymptomatic Liver Hemangioma, TAE should not be conducted.

  • Characteristics and operative treatment of extremely giant Liver Hemangioma >20 cm.
    Surgery, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Yongliang Sun, Liguo Liu, Jia Huang, Wenying Zhou
    Abstract:

    Background Giant Liver Hemangioma >20 cm may cause severe complications; therefore, operative treatment can be highly difficult and risky. No studies have been performed to determine the characteristics of this subgroup. Methods A retrospective study was performed on 141 patients who underwent operative treatment for Liver Hemangioma. The patients were divided into an extremely giant Hemangioma group (>20 cm, 36 cases) and a giant Hemangioma group (>10 cm but Results Compared with the giant Hemangioma group, patients in the extremely giant Hemangioma group had greater rates of leukopenia (P Conclusion Extremely giant Hemangiomas may cause abnormalities in the hematologic and coagulation systems. Operative treatment may be difficult and risky but can be completed safely.

  • Giant Liver Hemangioma with adult Kasabach-Merritt syndrome: Case report and literature review.
    Medicine, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Yongliang Sun, Liguo Liu, Wenying Zhou, Jia Huang
    Abstract:

    Adult Kasabach-Merritt syndrome associated with giant Liver Hemangioma is rare; to date, most reports have been single-case reports, and no multi-case reports or literature reviews are available. We conducted a retrospective analysis of 5 cases of adult Kasabach-Merritt syndrome associated with giant Liver Hemangioma treated at our hospital between 2011 and 2016. All 5 patients had varying severities of leukopenia, anemia, thrombocytopenia, prolonged prothrombin time, and hypofibrinogenemia. All the patients underwent surgery: 2 patients had left hemihepatectomy; 1 had enucleation; 1 had a right hemihepatectomy; and 1 had a left trisectionectomy. The 5 patients had an average operative time of 6.9 hours and an average blood loss of 3200 mL. One patient developed a biliary fistula (grade II) after the operation. There was no mortality among 5 patients. The white blood cell counts, hemoglobin, platelets, and prothrombin times of all 5 patients returned to normal after the operation. To date, a total of 11 cases of adult Kasabach-Merritt syndrome associated with giant Liver Hemangioma have been reported, of which 8 patients underwent surgery, and their platelets and coagulation returned to normal after the operation. Adult Kasabach-Merritt syndrome associated with giant Liver Hemangioma is uncommon, and surgical treatment is risky. However, resection of the tumor corrected the abnormalities in hematological and coagulative systems.

  • Long-term result of transcatheter arterial embolization for Liver Hemangioma.
    Medicine, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Liguo Liu, Jia Huang, Yongliang Sun
    Abstract:

    Transcatheter arterial embolization (TAE) is a method for the treatment of Liver Hemangioma, but fewer studies reported the long-term result.Retrospective study was conducted to Liver Hemangioma patients who received TAE. The inclusion criteria included the following: the period of follow-up was more than 5 years; and patients were followed up for less than 5 years, but received surgical treatment due to the enlargement of tumor or severe complications of TAE. The collected data included sex, age, size of the tumor, times of TAE, complications, period of follow-up, long-term result, and whether or not surgery was finally performed.Fifty-five patients were included, and the average age was 43.1 ± 8.6 years. The average size of Liver Hemangioma was 9.0 ± 4.3 cm. Four patients (7.3%) had severe complications after TAE, including 2 cases of biloma which were cured by surgery. The tumor size was smaller or the same in 19 patients after 5 years follow-up, and the long-term effective rate was 35.8%. The size of tumor became larger in the other 34 patients (64.2%), and 29 patients (54.7%) received surgery finally. The long-term effective rate for patients with ≥10 cm tumor and

Haidong Tan - One of the best experts on this subject based on the ideXlab platform.

  • Laparoscopic surgery for giant Liver Hemangiomas: a report of 40 patients
    Chinese Journal of Hepatobiliary Surgery, 2018
    Co-Authors: Zhiying Yang, Xiaolei Liu, Haidong Tan, Yongliang Sun, Liguo Liu, Wenying Zhou
    Abstract:

    Objective To analyze the clinical experience of laparoscopic surgery for giant Liver Hemangiomas. Methods The clinical data of 40 patients who underwent laparoscopic surgery for giant Liver Hemangiomas from August 2012 to January 2018 in the China-Japan Friendship Hospital were retrospectively analyzed. The diameters of the Liver Hemangiomas were more than 10 cm for all the patients. The Liver functions of all the patients were Child-Pugh class A. The follow-up was up to the end of February 2018. Results Laparoscopic treatment of giant Liver Hemangioma was successfully performed in 37 patients. Three patients were converted to open hepatectomy. The mean diameter of the giant Liver Hemangiomas was (10.8±1.3) cm (ranged 10.0~15.0 cm). The mean operative time for laparoscopic therapy was (154.7±68.0) min (range 70~390 min). The mean intraoperative blood loss was 200 (100~400) ml. 20 patients received autologous blood transfusion. Of these 2 patients received in addition allogeneic blood transfusion. The postoperative hospital stay was (6.9±2.0) days (range 4~14 days). Postoperative complications occurred in 3 patients (8.1%). Two patients developed postoperative pleural effusion and one pelvic effusion. Two patients responded well to puncture drainage and one to conservation management. There was no postoperative hemorrhage, bile leakage or air embolism. All patients were followed-up and no Liver Hemangioma recurrence was detected. Conclusion Laparoscopic surgery was a safe and efficacious procedure in selected patients with giant Liver Hemangioma. Key words: Liver Hemangioma; Laparoscopic surgery; Hepatectomy

  • Surgical treatment for giant Liver Hemangioma: an expeience on 119 cases
    Chinese Journal of General Surgery, 2018
    Co-Authors: Haidong Tan, Xiaolei Liu, Yongliang Sun, Liguo Liu, Jia Huang, Wenying Zhou
    Abstract:

    Objective To summarize the experience of surgical treatments for giant Liver Hemangioma. Methods A retrospective study was made on the clinical data of patients with Liver Hemangioma larger than 10 cm in diameter, which were divided into two groups (10-

  • long term result of transcatheter arterial embolization for Liver Hemangioma
    Medicine, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Liguo Liu, Jia Huang, Yongliang Sun
    Abstract:

    Transcatheter arterial embolization (TAE) is a method for the treatment of Liver Hemangioma, but fewer studies reported the long-term result.Retrospective study was conducted to Liver Hemangioma patients who received TAE. The inclusion criteria included the following: the period of follow-up was more than 5 years; and patients were followed up for less than 5 years, but received surgical treatment due to the enlargement of tumor or severe complications of TAE. The collected data included sex, age, size of the tumor, times of TAE, complications, period of follow-up, long-term result, and whether or not surgery was finally performed.Fifty-five patients were included, and the average age was 43.1 ± 8.6 years. The average size of Liver Hemangioma was 9.0 ± 4.3 cm. Four patients (7.3%) had severe complications after TAE, including 2 cases of biloma which were cured by surgery. The tumor size was smaller or the same in 19 patients after 5 years follow-up, and the long-term effective rate was 35.8%. The size of tumor became larger in the other 34 patients (64.2%), and 29 patients (54.7%) received surgery finally. The long-term effective rate for patients with ≥10 cm tumor and <10 cm tumor were 12.5% and 45.9%, respectively, and the difference was significant (P = .019).The long-term result of TAE for Liver Hemangioma was not satisfying, and the treatment had the risk of severe complication. For patients with asymptomatic Liver Hemangioma, TAE should not be conducted.

  • Risk factors of massive blood loss during resection of giant Liver Hemangioma
    Chinese Journal of Hepatobiliary Surgery, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Yongliang Sun, Liguo Liu, Wenying Zhou
    Abstract:

    Objective To evaluate the risk factors of massive blood loss in resection of giant Liver Hemangioma. Method The clinical data of 141 patients who underwent giant Liver Hemangioma resection were retrospectively studied. These data included general physical condition, laboratory tests, radiologic findings, and various surgical parameters. The patients were divided into the massive blood loss group (>1 000 ml, n=27) and the minor blood loss group (≤1 000 ml, n=114). Logistic regression was performed to determine the risk factors of intraoperative massive blood loss. Results The average diameter of the Liver Hemangioma was significantly greater in the massive blood loss group than that in the minor blood loss group [(21.7±8.5) cm vs. (14.1±5.3) cm, P

  • Extremely Giant Liver Hemangioma (50 cm) with Kasabach-Merritt Syndrome.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2017
    Co-Authors: Zhiying Yang, Xiaolei Liu, Haidong Tan, Yongliang Sun
    Abstract:

    A 33-year-old male has been found with a giant Liver Hemangioma of initial size 29 cm for 5 years. He received arterial embolization twice in order to shrink the tumor; however, no effect was obtained. The tumor had rapidly grown to 50 cm and caused abnormalities in the hematological and coagulative systems. Preoperative computed tomography revealed that the right hepatic vein, right hepatic artery, and right portal vein were not involved by the Hemangioma. Resection of the giant Liver Hemangioma was successfully performed after intraoperative intentional bloodletting with concurrent blood salvage. All hematological and coagulative abnormalities had returned to normal after the procedure.

Liguo Liu - One of the best experts on this subject based on the ideXlab platform.

  • Laparoscopic surgery for giant Liver Hemangiomas: a report of 40 patients
    Chinese Journal of Hepatobiliary Surgery, 2018
    Co-Authors: Zhiying Yang, Xiaolei Liu, Haidong Tan, Yongliang Sun, Liguo Liu, Wenying Zhou
    Abstract:

    Objective To analyze the clinical experience of laparoscopic surgery for giant Liver Hemangiomas. Methods The clinical data of 40 patients who underwent laparoscopic surgery for giant Liver Hemangiomas from August 2012 to January 2018 in the China-Japan Friendship Hospital were retrospectively analyzed. The diameters of the Liver Hemangiomas were more than 10 cm for all the patients. The Liver functions of all the patients were Child-Pugh class A. The follow-up was up to the end of February 2018. Results Laparoscopic treatment of giant Liver Hemangioma was successfully performed in 37 patients. Three patients were converted to open hepatectomy. The mean diameter of the giant Liver Hemangiomas was (10.8±1.3) cm (ranged 10.0~15.0 cm). The mean operative time for laparoscopic therapy was (154.7±68.0) min (range 70~390 min). The mean intraoperative blood loss was 200 (100~400) ml. 20 patients received autologous blood transfusion. Of these 2 patients received in addition allogeneic blood transfusion. The postoperative hospital stay was (6.9±2.0) days (range 4~14 days). Postoperative complications occurred in 3 patients (8.1%). Two patients developed postoperative pleural effusion and one pelvic effusion. Two patients responded well to puncture drainage and one to conservation management. There was no postoperative hemorrhage, bile leakage or air embolism. All patients were followed-up and no Liver Hemangioma recurrence was detected. Conclusion Laparoscopic surgery was a safe and efficacious procedure in selected patients with giant Liver Hemangioma. Key words: Liver Hemangioma; Laparoscopic surgery; Hepatectomy

  • Surgical treatment for giant Liver Hemangioma: an expeience on 119 cases
    Chinese Journal of General Surgery, 2018
    Co-Authors: Haidong Tan, Xiaolei Liu, Yongliang Sun, Liguo Liu, Jia Huang, Wenying Zhou
    Abstract:

    Objective To summarize the experience of surgical treatments for giant Liver Hemangioma. Methods A retrospective study was made on the clinical data of patients with Liver Hemangioma larger than 10 cm in diameter, which were divided into two groups (10-

  • long term result of transcatheter arterial embolization for Liver Hemangioma
    Medicine, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Liguo Liu, Jia Huang, Yongliang Sun
    Abstract:

    Transcatheter arterial embolization (TAE) is a method for the treatment of Liver Hemangioma, but fewer studies reported the long-term result.Retrospective study was conducted to Liver Hemangioma patients who received TAE. The inclusion criteria included the following: the period of follow-up was more than 5 years; and patients were followed up for less than 5 years, but received surgical treatment due to the enlargement of tumor or severe complications of TAE. The collected data included sex, age, size of the tumor, times of TAE, complications, period of follow-up, long-term result, and whether or not surgery was finally performed.Fifty-five patients were included, and the average age was 43.1 ± 8.6 years. The average size of Liver Hemangioma was 9.0 ± 4.3 cm. Four patients (7.3%) had severe complications after TAE, including 2 cases of biloma which were cured by surgery. The tumor size was smaller or the same in 19 patients after 5 years follow-up, and the long-term effective rate was 35.8%. The size of tumor became larger in the other 34 patients (64.2%), and 29 patients (54.7%) received surgery finally. The long-term effective rate for patients with ≥10 cm tumor and <10 cm tumor were 12.5% and 45.9%, respectively, and the difference was significant (P = .019).The long-term result of TAE for Liver Hemangioma was not satisfying, and the treatment had the risk of severe complication. For patients with asymptomatic Liver Hemangioma, TAE should not be conducted.

  • Risk factors of massive blood loss during resection of giant Liver Hemangioma
    Chinese Journal of Hepatobiliary Surgery, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Yongliang Sun, Liguo Liu, Wenying Zhou
    Abstract:

    Objective To evaluate the risk factors of massive blood loss in resection of giant Liver Hemangioma. Method The clinical data of 141 patients who underwent giant Liver Hemangioma resection were retrospectively studied. These data included general physical condition, laboratory tests, radiologic findings, and various surgical parameters. The patients were divided into the massive blood loss group (>1 000 ml, n=27) and the minor blood loss group (≤1 000 ml, n=114). Logistic regression was performed to determine the risk factors of intraoperative massive blood loss. Results The average diameter of the Liver Hemangioma was significantly greater in the massive blood loss group than that in the minor blood loss group [(21.7±8.5) cm vs. (14.1±5.3) cm, P

  • Characteristics and operative treatment of extremely giant Liver Hemangioma >20 cm.
    Surgery, 2017
    Co-Authors: Xiaolei Liu, Zhiying Yang, Haidong Tan, Yongliang Sun, Liguo Liu, Jia Huang, Wenying Zhou
    Abstract:

    Background Giant Liver Hemangioma >20 cm may cause severe complications; therefore, operative treatment can be highly difficult and risky. No studies have been performed to determine the characteristics of this subgroup. Methods A retrospective study was performed on 141 patients who underwent operative treatment for Liver Hemangioma. The patients were divided into an extremely giant Hemangioma group (>20 cm, 36 cases) and a giant Hemangioma group (>10 cm but Results Compared with the giant Hemangioma group, patients in the extremely giant Hemangioma group had greater rates of leukopenia (P Conclusion Extremely giant Hemangiomas may cause abnormalities in the hematologic and coagulation systems. Operative treatment may be difficult and risky but can be completed safely.